N-Cyano-4-methyl-N-phenylbenzenesulfonamide, 95.0%, 250mg

4-(3-bromophenyl)-3H,4H,5H,6H,7H-imidazo[4,5-c]pyridine-6-carboxylic acid, 95.0%, 1g

TERT-BUTYL 3-BENZYL-3,6-DIAZABICYCLO[3.1.1]HEPTANE-6-CARBOXYLATE, 95.0%, 500mg

(2r)-2-(4-Bromophenyl)-4-[(1s)-1-phenylethyl]morpholine, 98%, 100mg

Sample stands ONERACK® for tube 30 mm, green, 8 Piece(s)

(4-Methyl-2-thioxo-2,3-dihydro-thiazol-5-yl)-acetic acid, 97.0%, 5g

4-Heptylaniline>98.0%(GC)(T)5mL

Methyl 4-bromo-2-(bromomethyl)-6-fluorobenzoate, 98%, 250mg

(S)-4-Methyl-2-(methylamino)pentanoic acid, 95.0%, 5g

4-Sulfophthalic acid, 80.0%, 500ml

tert-Butyl (R)-3-((R)-(3-chlorophenyl)(hydroxy)methyl)piperidine-1-carboxylate, 95%, 250mg

EDTA magnesium disodium salt x H2O, min. 90%, for synthesis, 500 g, plastic packaging.

Ethanesulfinic acid, sodium salt, 85.0%, 100g